DIEBOLD INCInsider Trading & SEC Form 4 Analysis
Institutional analysis of internal capital flows based on SEC Form 4 filings.
-$180.7M
Buys minus sales2026.06.26
Latest Form 415
Reporting entitiesBaur Frank Tobias
$220.0KMillstreet Capital Management LLC
$34.0MAutomated_Intelligence_Report :: DBD
Algorithmic analysis of recent insider trading activity for DBD reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 15 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $189.00M.
Market dynamics show a negative net capital flow of $180.70M when isolating open-market purchases versus open-market sales. The trading volume is heavily weighted towards open-market executions, providing a clearer signal of insider conviction regarding current valuation levels compared to option-based equity grants.
From a microstructural perspective, the landscape is fragmented. Baur Frank Tobias led the buying pressure, while Millstreet Capital Management LLC registered the largest single offload of shares. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of DBD.
$189.00M
USD NOMINAL VALUE15
UNIQUE C-SUITE ENTITIES2026.06.26
ISO_8601 FORMATAutomated_Queries :: Frequently Asked Questions
>How many corporate insiders are active in DBD?
Our dataset currently tracks 15 distinct insiders with reported transactions for DBD in the active reporting window.
>Is insider buying outweighing selling at DBD?
Open-market selling volume ($181.66M) currently exceeds buying volume ($0.96M), indicating net liquidation by insiders.
>Who is currently buying DBD stock?
Based on the latest SEC Form 4 filings, Baur Frank Tobias (Officer/Other) has been actively acquiring shares. The total recent insider buying volume stands at $0.96M.